Melanoma Skin clinical trials

Explore recruiting melanoma skin clinical trials.

Recruiting melanoma skin studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Melanoma Skin trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2, open label study to evaluate safety and clinical activity of balstilimab in monotherapy in patients with advanced/metastatic non-melanoma skin cancers (AGENONMELA).

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions.

Poland, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to investigate the efficacy and safety of daxdilimab subcutaneous injection in reducing disease activity in adult participants with moderate-to-severe primary discoid lupus erythematosus.

Denmark, France, Czechia, Germany, Poland, Greece +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Efficacyand Safety Study Of Daxdilimab Subcutaneous Injection In Adult Participants With Inadequately Controlled Dermatomyositis Or Anti-Synthetase Inflammatory Myositis

Spain, Italy, Germany, Czechia, France

Therapeutic exploratory (Phase II) EU CTIS Study details

C4221023 - A PHASE 2, RANDOMIZED, OPEN-LABEL STUDY OF ENCORAFENIB AND BINIMETINIB PLUS PEMBROLIZUMAB VERSUS NIVOLUMAB AND IPILIMUMAB IN PARTICIPANTS WITH BRAF V600E/K MUTATION-POSITIVE MELANOMA WHO PROGRESSED DURING OR AFTER PRIOR TREATMENT WITH ANTI−PD-1 THERAPY

Spain, Germany, Slovakia, Italy, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Melanoma Skin trials by city

Melanoma Skin in Toronto Melanoma Skin in Vancouver Melanoma Skin in Montreal Melanoma Skin in Calgary Melanoma Skin in Edmonton Melanoma Skin in Ottawa Melanoma Skin in Winnipeg Melanoma Skin in Quebec City Melanoma Skin in Hamilton Melanoma Skin in Kitchener Melanoma Skin in London Melanoma Skin in Halifax Melanoma Skin in New York Melanoma Skin in Los Angeles Melanoma Skin in Chicago Melanoma Skin in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease